ClinicalTrials.Veeva

Menu

mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism

U

University of Monastir

Status

Not yet enrolling

Conditions

Bruxism

Treatments

Genetic: Genetic polymorphism

Study type

Observational

Funder types

Other

Identifiers

NCT06457646
0000-0002-5945-7764 (Other Identifier)
011/2021

Details and patient eligibility

About

The goal of this observational study is to learn about the genetic factors influencing bruxism, a condition characterized by teeth grinding, in a group of participants. The main questions it aims to answer are:

  • Is there a significant association between the rs6313 polymorphism of the HTR2A gene and bruxism?
  • Is there a significant association between the rs6280 polymorphism of the DRD3 gene and bruxism?

Participants will:

Provide DNA samples for genotyping of the DRD3 (rs6280) and HTR2A (rs6313) polymorphisms.

Provide RNA samples to assess changes in the expression of HTR2A and DRD3. Researchers will compare the genetic data and RNA expression levels between individuals with bruxism and those without (controls) to see if there are significant genetic differences and expression changes associated with bruxism.

Enrollment

169 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • be above 18 years of age and have a confirmed diagnosis of bruxism

Exclusion criteria

  • Systemic diseases,
  • orofacial dysfunction,
  • acute symptoms such as neurodegenerative diseases (specifically Parkinsons disease),
  • Taking medication such as anxiolytics

Trial contacts and locations

0

Loading...

Central trial contact

Yosra Gassara

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems